Trial Profile
A Multicenter, Historical Control Study to Evaluate the Effects of Personalized Patient Counselling on Persistence to Enbrel® Therapy in Subjects With Rheumatoid Arthritis (PerSuit)
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 31 Mar 2017
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Diagnostic use
- Acronyms PerSuit
- Sponsors Amgen
- 01 Dec 2015 Status changed from recruiting to discontinued as reported by Clinicaltrials.gov.
- 27 May 2015 New trial record